Exploring the Role of Tumor Suppressor Enhancers in the Development of T-cell Acute Lymphoblastic Leukemia

Researchers from Rutgers Cancer Institute of New Jersey identified a novel enhancer that interacts with a tumor suppressor gene and explored its involvement in normal T-cell development as well as in T-cell acute lymphoblastic leukemia (T-ALL).

Read more

Studying Patterns of Relapse in Pediatric Hodgkin Lymphoma using a Response-Based Therapy Approach

Recent research from Rutgers Cancer Institute of New Jersey expert as part of a phase 3 study from the Children’s Oncology Group explores response-based consolidation with modern radiation therapy as safe and effective standard of care for pediatric Hodgkin lymphoma patients. This work is being presented at the Annual Meeting of the American Society for Radiation Oncology (ASTRO) this week.

Read more

Rutgers Cancer Institute of New Jersey Awarded $1.6M for Rutgers Youth Enjoy Science (RUYES) Program for Underrepresented Youth and Educators

The Rutgers Youth Enjoy Science (RUYES) program, funded by the National Cancer Institute, will engage underrepresented minority undergraduate and high school students in cutting-edge cancer research, curriculum support, and professional development activities.

Read more

Presence of Cumulative Physiological Stress Prior to Diagnosis Linked to Poor Health-Related Quality of Life in African American and Black Breast Cancer Survivors

Rutgers University investigators conducted a study to determine the association of pre-diagnostic allostatic load, which is a composite measure of cumulative physiological stress and wear and tear on the body, with health-related quality of life in African American and Black survivors of breast cancer.

Read more

$50K Grant Supports Exploration of Treatment for Liver Cancer

Incidence and mortality of hepatocellular carcinoma (HCC), a common type of liver cancer, is increasing in the United States. Rutgers Cancer Institute of New Jersey experts have received a $50,000 award through the Translational Research Pilot Award Program that will support the examination of how a drug combination impacts the growth of both human HCC cancer cells and tumors in laboratory models, with the goal of identifying a new treatment for patients with this disease.

Read more

Thyroid Cancer: Small Gland, Big Impact

The thyroid is a key part of the endocrine system, a small gland at the base of your neck that produces a hormone that helps control your body’s metabolism. One of the most common and treatable cancers in the United States is thyroid cancer. Rutgers Cancer Institute expert discusses research and treatment for this disease.

Read more